Order Article Reprints

Mireștean CC, Stan MC, Schenker M, Volovăț C, Volovăț SR, Iancu DTP, Iancu RI, Bădulescu F. Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review. Diagnostics. 2023; 13(16):2620. https://doi.org/10.3390/diagnostics13162620

Mireștean, Camil Ciprian, Mihai Cosmin Stan, Michael Schenker, Constantin Volovăț, Simona Ruxandra Volovăț, Dragoș Teodor Petru Iancu, Roxana Irina Iancu, and Florinel Bădulescu. 2023. "Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review" Diagnostics 13, no. 16: 2620. https://doi.org/10.3390/diagnostics13162620

Mireștean, C. C., Stan, M. C., Schenker, M., Volovăț, C., Volovăț, S. R., Iancu, D. T. P., Iancu, R. I., & Bădulescu, F. (2023). Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review. Diagnostics, 13(16), 2620. https://doi.org/10.3390/diagnostics13162620